Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)
~72 mi.
(Kursk,
Russia,
+159 more cities)
Kursk Regional Clinical Oncology Dispensary ( Site 0854)